A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion
Conclusion: The use of letrozole pretreatment (7.5 mg daily for 3 days) with misoprostol in second-trimester abortion does not significantly improve the abortion rate of the misoprostol-only regimen. (Source: Contraception)
A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS
Conclusion(s)nbsp;nbsp;The results of this study did not show any advantage to the use of 7.5nbsp;mg/day over 5nbsp;mg/day dose of Letrozole as the first
line treatment for induction of ovulation in women with PCOS.
Content Type Journal ArticlePages 1-6DOI 10.1007/s00404-011-1951-5Authors
Fatemeh Ramezanzadeh, Vali-E-asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, IranRoya Nasiri, Department of Obstetrics and Gynecology, Mashhad Branch, Islamic Azad University, Mashhad, IranMohammad Sarafraz Yazdi, Department of Internal Medicine - Endocrine Unit, Mashhad Branch, Islamic Azad University, Mashhad, IranMaryam Baghrei, Vali-E-asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
Journal Archi...
